How the Indian SMDI Scheme Will Transform Medical Devices

India currently imports a significant portion of its medical devices. Consequently, the Ministry of Chemicals and Fertilisers launched the SMDI scheme to encourage domestic production. This central sector scheme features an overall outlay of Rs 500 crore. Specifically, the Department of Pharmaceuticals (DoP) is targeting two key areas through its latest call for proposals. The initiative aims to reduce import dependence while building domestic capabilities. Furthermore, it strengthens local supply chains for raw materials and advanced components.

Applying the SMDI Scheme for Import Reduction

Under this sub-scheme, the government provides financial incentives to domestic manufacturers. Specifically, eligible companies can receive a one-time capital subsidy of up to Rs 10 crore. Importantly, the department processes these disbursements on a reimbursement basis. This funding supports the local production of key components, accessories, and raw materials. Consequently, Indian manufacturers will face fewer procurement bottlenecks. Additionally, small and medium enterprises can benefit from this initiative to upgrade their infrastructure, fostering an environment where professionals can focus on improving medical practice standards.

Clinical Study Support Under MDCSS

The second sub-scheme is the Medical Device Clinical Studies Support Scheme (MDCSS). Under MDCSS, the government offers up to Rs 5 crore in financial assistance. Therefore, eligible clinical researchers and developers can use this support to evaluate safety and efficacy. Specifically, the financial assistance covers clinical investigations and performance evaluations. Additionally, developers can use these funds for post-market follow-up studies and animal testing. This financial support will ultimately help local innovations achieve international standards of credibility, essential for those involved in clinical drug development.

Application Procedure and Important Deadlines

Eligible entities must submit their proposals online through the official portal. The dedicated portal is accessible at http://smdi.lsssdc.in. Moreover, the final deadline for online submission is July 23, 2026, at 6:00 PM. Subsequently, interested applicants should thoroughly review the detailed operational guidelines. These guidelines are available on the Department of Pharmaceuticals website.

Frequently Asked Questions

Q1: What is the maximum subsidy available under the SMDI scheme?

Eligible candidates can receive up to Rs 10 crore under the Marginal Investment Scheme and up to Rs 5 crore under the Medical Device Clinical Studies Support Scheme (MDCSS).

Q2: What is the last date to apply for this government subsidy?

Eligible entities must submit their online proposals on or before July 23, 2026, at 6:00 PM.

Q3: How are the funds disbursed under the SMDI sub-schemes?

The Department of Pharmaceuticals disburses the funds on a reimbursement basis after verifying eligible capital expenditures and clinical research costs.

References

1. Govt invites proposals for medical device manufacturing; offers up to Rs 10crore subsidy – ETHealthworld
2. Government Invites Proposals under the Scheme for Strengthening of Medical Device Industry (SMDI) – PIB
3. DoP calls for proposals under two sub-schemes of SMDI – Pharmabiz.com
4. DoP Issues Guidelines for INR 500 Cr Medical Device Industry Scheme

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.